PTEN and breast cancer: AKT pathway: In clinical BC samples and cell lines, phosphatase and tensin homolog (PTEN) and PTEN pseudogene 1 (PTENP1) are concomitantly downregulated and the overexpression of PTENP1 and PTEN suppress BC progression.